top of page
Norwegian Cancer Precision Medicine Implementation Consortium
Latest news
CONNECT Seminar on Real-World Data
Learn more about the use of real-world data (RWD) for regulatory processes from two presentations held at a recent CONNECT meeting.
May 31, 20212 min read
CONNECT Seminar on Horizon Scanning Methods
Learn more about Horizon Scanning Methods from the presentations held at a recent CONNECT meeting.
May 12, 20211 min read
First pharma company joins IMPRESS-Norway
Roche is the first pharmaceutical company included in the national clinical study in cancer precision medicine called IMPRESS-Norway.
Jan 29, 20213 min read
Landmark public-private agreement for precision cancer medicine
CONNECT is a new initiative aiming to ensure that precision medicine reaches the patients.
Dec 21, 20203 min read
IMPRESS NORWAY: Large national precision medicine study in cancer
IMPRESS-Norway, a large national study on precision medicine against cancer, starts in the beginning of 2021.
Oct 13, 20203 min read
bottom of page